ResearcherUniversidade Federal de PernambucoActive in the last 2 years

Joelson Germano Crispim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3057-1299; OpenAlex author ID A5010030596. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

Interactions between the nervous system and PDAC progression: Regulatory mechanisms and therapeutic implications. Co-author DOI 10.1016/j.ejphar.2026.178829 ↗
Multimodal Activity of a Novel Compound against Prostate and Pancreatic Cancer. First author DOI 10.2174/0115680266351687250309020134 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Michelle Melgarejo da Rosa · 2 shared papers, 2025–2026 · strength 0.66
- Paper Interactions between the nervous system and PDAC progression: Regulatory mechanisms and therapeutic implications. DOI 10.1016/j.ejphar.2026.178829 ↗
- Paper Multimodal Activity of a Novel Compound against Prostate and Pancreatic Cancer. DOI 10.2174/0115680266351687250309020134 ↗
Moacyr Jesus Barreto de Melo Rêgo · 2 shared papers, 2025–2026 · strength 0.66
- Paper Interactions between the nervous system and PDAC progression: Regulatory mechanisms and therapeutic implications. DOI 10.1016/j.ejphar.2026.178829 ↗
- Paper Multimodal Activity of a Novel Compound against Prostate and Pancreatic Cancer. DOI 10.2174/0115680266351687250309020134 ↗
Flaviana Alves dos Santos · 1 shared paper, 2025 · strength 0.23
- Paper Multimodal Activity of a Novel Compound against Prostate and Pancreatic Cancer. DOI 10.2174/0115680266351687250309020134 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.